Delivery Order SPE2DB22D2006-SPE2DB25FW3FF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare systems. This competitively awarded, non-set-aside contract is valued at $16,184.74 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare settings. This non-set-aside, competitively awarded delivery order carries a ceiling value of $1,291.80 under firm fixed price terms, with a completion date of September 22, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $14.7K delivery order to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, an antifungal medication used for serious systemic fungal infections. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal medication used in military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order has a ceiling value of $10,099.14 with an ultimate completion date of August 25, 2025. The contract was fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal pharmaceutical product. This competitively awarded, non-set-aside contract carries a ceiling value of $7,741.00 with firm fixed pricing and an ultimate completion date of September 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $9,532.30 delivery order to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, a critical antifungal medication used in military and federal healthcare systems. This firm fixed-price contract, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,975.20 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559476979 AMBISOME 50 MG VIALS. This contract has an ultimate completion date of January 3, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,846.96 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,153,581 units of AMBISOME 50 MG VIALS by December 21, 2023. As a prime contractor, Amerisourcebergen Drug Corp has a long history of supplying pharmaceuticals, medical supplies, and distribution services to DLA Troop Support Medical facilities. This delivery order was not set aside and is part of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AMBISOME 50 MG VIALS. The delivery order has a potential value of $1,923.48 and a completion date of December 26, 2023. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to the Department of Defense, providing pharmaceutical products and medical supplies to support military...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3FFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,906.55 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of AmBisome 50 mg vials. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. AmBisome is an antifungal medication used to treat serious systemic fungal infections, reflecting the critical role of pharmaceutical distributors in supporting military and federal healthcare operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The arrangement allows AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through a flexible contracting mechanism, positioning the company as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/7/25 |